When missing segments of the genome matter in cancer, it's bad news because those deletions have wiped out a gene that blocks or hinders cancer formation and growth.

But now scientists have found genomic deletions that expose weaknesses to exploit in malignant cells. These deletions occur as collateral damage to neighboring genes when tumor-suppressors are destroyed.

This week in Nature, Florian Muller, Ph.D., instructor...